GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Piramal Pharma PPLPHARMA.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

246.37

+2.95%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹88.69bn

FY2021FY2026

Net income

−₹3.26bn

FY2021FY2026

Free cash flow

₹5.10bn

FY2021FY2026

Shareholders' equity

₹81.63bn

FY2021FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
Revenue₹88.69bn₹90.61bn₹81.06bn₹70.32bn₹64.72bn₹29.00bn
Research and development₹1.11bn₹971.3m₹1.01bn₹863.6m₹1.28bn₹691.4m
Operating income₹903.8m₹6.79bn₹4.62bn−₹479.7m₹6.74bn₹4.81bn
Net income−₹3.26bn₹911.3m₹178.2m−₹1.86bn₹3.76bn₹5.71bn
Diluted earnings per share-2.460.690.15-1.483.094.70

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Total assets₹179.65bn₹156.78bn₹153.12bn₹145.23bn₹127.97bn₹57.57bn
Cash and short-term investments₹13.55bn₹5.21bn₹5.02bn₹6.60bn₹3.79bn₹1.62bn
Total liabilities₹98.02bn₹75.52bn₹74.00bn₹77.49bn₹61.00bn₹16.56bn
Debt₹56.75bn₹48.56bn₹47.10bn₹56.37bn₹41.28bn₹1.74bn
Shareholders' equity₹81.63bn₹81.25bn₹79.11bn₹67.73bn₹66.97bn₹41.01bn
Shares outstanding1,323m1,321m1,227m1,264m1,219m1,217m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
Cash from operations₹14.00bn₹8.92bn₹10.05bn₹4.84bn₹2.55bn₹347.2m
Capital spending−₹8.90bn−₹6.64bn−₹7.12bn−₹9.65bn−₹2.01bn−₹581.1m
Free cash flow₹5.10bn₹2.28bn₹2.92bn−₹4.81bn₹546.9m−₹233.9m
Dividends paid−₹185.5m−₹144.7m—−₹670.0m−₹500.0m−₹500.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹22.70bn₹27.52bn₹21.40bn₹20.44bn₹19.34bn₹26.64bn₹22.04bn₹22.42bn
Operating income−₹283.5m₹2.42bn−₹170.1m−₹441.5m−₹905.8m₹3.68bn₹1.41bn₹1.49bn
Net income−₹693.9m−₹88.2m−₹1.36bn−₹992.2m−₹817.0m₹1.53bn₹36.8m₹225.9m
Diluted earnings per share-0.52-0.07-1.03-0.75-0.621.160.030.18
Cash from operations———₹8.90bn————
Capital spending———−₹4.33bn————
Free cash flow———₹4.57bn————
Total assets—₹179.65bn—₹161.89bn—₹156.78bn—₹152.42bn
Cash and short-term investments₹13.55bn₹13.55bn₹7.44bn₹7.44bn₹4.08bn₹5.21bn₹4.08bn₹4.08bn
Debt—₹55.39bn—₹14.35bn—₹47.57bn—₹46.78bn
Shareholders' equity₹81.63bn₹81.63bn₹80.74bn₹80.74bn₹81.25bn₹81.25bn₹79.07bn₹79.07bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.4%24.1%—
Operating income—-28.4%—
Net income20.5%——

Average margins

Over each period

1 year3 years5 years10 years
Operating margin4.3%3.6%5.5%—
Net margin-1.3%-1.2%1.3%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022
Price to earnings-97.3249.7—-94.136.3
Price to sales3.72.64.32.62.2

Dividends and splits

Per share, in the currency the company pays

Paid for 2 years. Last went ex-dividend on 16 Jul 2025.

FY2026FY2025
Paid in the year0.140.11

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.